Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-11-040166
Filing Date
2011-07-12
Accepted
2011-07-12 16:16:44
Documents
2
Period of Report
2011-07-12

Document Format Files

Seq Description Document Type Size
1 v228488_6-k.htm 6-K 29513
2 GRAPHIC logo.jpg GRAPHIC 2155
  Complete submission text file 0001144204-11-040166.txt   33629
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 11964111
SIC: 2834 Pharmaceutical Preparations